| Authors: |
Allen JD; Dana-Farber Cancer Institute, Boston, MA, USA. jennifer.allen@tufts.edu.; Department of Public Health and Community Medicine, Tufts University, 112 Packard Ave, Medford, MA, 02155, USA. jennifer.allen@tufts.edu., Torres MI; Mauricio Gaston Institute for Latino Community Development and PublicPolicy, University of Massachusetts, Boston, MA, USA. idali.torres@umb.edu., Tom LS; Dana-Farber Cancer Institute, Boston, MA, USA. laura.tom@harvard.edu., Rustan S; Mauricio Gaston Institute for Latino Community Development and PublicPolicy, University of Massachusetts, Boston, MA, USA. sarah.rustan@umb.edi., Leyva B; National Cancer Institute, Bethesda, MD, USA. bryan.leyvavengoechea@nih.gov., Negron R; Mauricio Gaston Institute for Latino Community Development and PublicPolicy, University of Massachusetts, Boston, MA, USA. rosalyn.negron@umb.edu., Linnan LA; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. linnan@email.unc.edu., Jandorf L; Icahn School of Medicine at Mount Sinai, New York, NY, USA. lina.jandorf@mssm.edu., Ospino H; Boston College, Chestnut Hill, MA, USA. ospino2@bc.edu. |